Rights and permissions About this article Cite this article Crane, J., Zhao, L., Frye, J
It activates the tyrosine kinase activity of IGF-1 receptor (IGF-1R), induces downstream MAPK/ERK and PI3K/Akt pathways, promotes the expression of cell cycle proteins (Cyclin D1, E), and accelerates the transition of cells from G1 phase to Sphase
In summary, CPP-CAND is a FOXO4-p53 interaction inhibitor that is anticipated to offer cost-effectiveness, high selectivity, and safety compared to previously developed peptide interaction inhibitors
A small, randomized, controlled, crossover trial involved 18 participants, average age 51 years, with obesity and prediabetes who underwent a 10-week intervention with cinnamon (4 grams per day) or placebo